1. Home
  2. AX vs GRFS Comparison

AX vs GRFS Comparison

Compare AX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$99.14

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.26

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
GRFS
Founded
1999
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.9B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
AX
GRFS
Price
$99.14
$7.26
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$103.14
$10.15
AVG Volume (30 Days)
394.0K
701.4K
Earning Date
04-30-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
6.33
N/A
Revenue
$65,789,000.00
N/A
Revenue This Year
$24.76
$4.49
Revenue Next Year
$10.86
$6.42
P/E Ratio
$15.96
$18.67
Revenue Growth
1.78
N/A
52 Week Low
$74.89
$6.96
52 Week High
$102.18
$11.14

Technical Indicators

Market Signals
Indicator
AX
GRFS
Relative Strength Index (RSI) 63.49 46.95
Support Level $85.44 $6.96
Resistance Level $100.42 $7.73
Average True Range (ATR) 2.51 0.17
MACD 0.06 0.03
Stochastic Oscillator 67.48 64.89

Price Performance

Historical Comparison
AX
GRFS

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: